Advertisement

DGKζ activates airways

Asthma is characterized by both T cell–mediated inflammation and airway smooth muscle cell hyperreactivity. In T cells, activation stimulates production of the second messenger diglycerol (DAG), which is converted into phosphatidic acid by diacylglycerol kinase ζ (DGKζ) to terminate DAG signaling. In a mouse model of asthma, Singh et al. found that genetic and pharmacological inhibition of DGK activity reduced both airway contraction and allergic inflammation. Unexpectedly, loss of DGKζ in immune and nonimmune cells had separable effects on allergic inflammation in the lung and airway hyperreactivity. Thus, DGK activity in both T cells and smooth muscle cells contributes to asthma, which is responsive to DGK inhibition in mice.

Abstract

Asthma is a chronic allergic inflammatory airway disease caused by aberrant immune responses to inhaled allergens, which leads to airway hyperresponsiveness (AHR) to contractile stimuli and airway obstruction. Blocking T helper 2 (TH2) differentiation represents a viable therapeutic strategy for allergic asthma, and strong TCR-mediated ERK activation blocks TH2 differentiation. Here, we report that targeting diacylglycerol (DAG) kinase zeta (DGKζ), a negative regulator of DAG-mediated cell signaling, protected against allergic asthma by simultaneously reducing airway inflammation and AHR though independent mechanisms. Targeted deletion of DGKζ in T cells decreased type 2 inflammation without reducing AHR. In contrast, loss of DGKζ in airway smooth muscle cells decreased AHR but not airway inflammation. T cell–specific enhancement of ERK signaling was only sufficient to limit type 2 airway inflammation, not AHR. Pharmacological inhibition of DGK diminished both airway inflammation and AHR in mice and also reduced bronchoconstriction of human airway samples in vitro. These data suggest that DGK is a previously unrecognized therapeutic target for asthma and reveal that the inflammatory and AHR components of asthma are not as interdependent as generally believed.
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Supplementary Material

Summary

Fig. S1. DGKζ KO T cells display impaired TH2 differentiation in vitro.
Fig. S2. DGKζ KO T cells display attenuated TH2 differentiation at early time points.
Fig. S3. Addition of exogenous IL-4 restores TH2 differentiation in DGKζ KO T cells.
Fig. S4. DGKα KO mice are partially protected from OVA-induced allergic airway inflammation and AHR.
Fig. S5. Loss of DGKζ selectively impairs the ability of T cells to produce IL-4 in a T cell–intrinsic manner during TH2 differentiation in vivo.
Fig. S6. Myh11-Cre is not a driver of the reduction in tension of Myh11-Cre DGKfl/fl tracheal rings in response to methacholine.
Fig. S7. Inhibition of ERK signaling is sufficient to restore TH2 differentiation in DGKζ KO T cells.
Table S1. Flow cytometry antibodies.
Table S2. Immunoblotting antibodies.

Resources

File (aax3332_sm.pdf)

REFERENCES AND NOTES

1
S. B. Barnett, T. A. Nurmagambetov, Costs of asthma in the United States: 2002–2007. J. Allergy Clin. Immunol. 127, 145–152 (2011).
2
B. N. Lambrecht, H. Hammad, The immunology of asthma. Nat. Immunol. 16, 45–56 (2015).
3
J. V. Fahy, Type 2 inflammation in asthma – present in most, absent in many. Nat. Rev. Immunol. 15, 57–65 (2015).
4
R. M. Locksley, Asthma and allergic inflammation. Cell 140, 777–783 (2010).
5
I. D. Pavord, R. Beasley, A. Agusti, G. P. Anderson, E. Bel, G. Brusselle, P. Cullinan, A. Custovic, F. M. Ducharme, J. V. Fahy, U. Frey, P. Gibson, L. G. Heaney, P. G. Holt, M. Humbert, C. M. Lloyd, G. Marks, F. D. Martinez, P. D. Sly, E. von Mutius, S. Wenzel, H. J. Zar, A. Bush, After asthma: Redefining airways diseases. Lancet 391, 350–400 (2017).
6
H. J. Waalkens, E. E. Van Essen-Zandvliet, M. D. Hughes, J. Gerritsen, E. J. Duiverman, K. Knol, K. F. Kerrebijn; Dutch CNSLD Study Group, Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am. Rev. Respir. Dis. 148, 1252–1257 (1993).
7
T. Haahtela, M. Järvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, O. Selroos, A. Sovijärvi, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, L. A. Laitinen, Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331, 700–705 (1994).
8
P. G. Woodruff, B. Modrek, D. F. Choy, G. Jia, A. R. Abbas, A. Ellwanger, J. R. Arron, L. L. Koth, J. V. Fahy, T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180, 388–395 (2009).
9
G. P. Anderson, Endotyping asthma: New insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372, 1107–1119 (2008).
10
L. Cohn, R. J. Homer, A. Marinov, J. Rankin, K. Bottomly, Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186, 1737–1747 (1997).
11
L. Cohn, J. S. Tepper, K. Bottomly, IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161, 3813–3816 (1998).
12
L. Cohn, R. J. Homer, H. MacLeod, M. Mohrs, F. Brombacher, K. Bottomly, Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J. Immunol. 162, 6178–6183 (1999).
13
G. G. Brusselle, J. C. Kips, J. H. Tavernier, J. G. van der Heyden, C. A. Cuvelier, R. A. Pauwels, H. Bluethmann, Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 24, 73–80 (1994).
14
D. B. Corry, H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, R. M. Locksley, Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183, 109–117 (1996).
15
M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, D. D. Donaldson, Interleukin-13: Central mediator of allergic asthma. Science 282, 2258–2261 (1998).
16
G. Grünig, M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, D. B. Corry, Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261–2263 (1998).
17
P. Licona-Limón, L. K. Kim, N. W. Palm, R. A. Flavell, TH2, allergy and group 2 innate lymphoid cells. Nat. Immunol. 14, 536–542 (2013).
18
R. L. Coffman, J. Carty, A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J. Immunol. 136, 949–954 (1986).
19
R. L. Coffman, J. Ohara, M. W. Bond, J. Carty, A. Zlotnik, W. E. Paul, B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136, 4538–4541 (1986).
20
E. S. Vitetta, J. Ohara, C. D. Myers, J. E. Layton, P. H. Krammer, W. E. Paul, Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med. 162, 1726–1731 (1985).
21
G. Le Gros, S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, W. E. Paul, Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells. J. Exp. Med. 172, 921–929 (1990).
22
S. Constant, C. Pfeiffer, A. Woodard, T. Pasqualini, K. Bottomly, Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182, 1591–1596 (1995).
23
N. A. Hosken, K. Shibuya, A. W. Heath, K. M. Murphy, A. O’Garra, The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182, 1579–1584 (1995).
24
X. Tao, S. Constant, P. Jorritsma, K. Bottomly, Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J. Immunol. 159, 5956–5963 (1997).
25
I. C. Rulifson, A. I. Sperling, P. E. Fields, F. W. Fitch, J. A. Bluestone, CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158, 658–665 (1997).
26
A. G.-H. Jember, R. Zuberi, F.-T. Liu, M. Croft, Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J. Exp. Med. 193, 387–392 (2001).
27
J. A. Gonzalo, J. Tian, T. Delaney, J. Corcoran, J. B. Rottman, J. Lora, A. Al-garawi, R. Kroczek, J. C. Gutierrez-Ramos, A. J. Coyle, ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses. Nat. Immunol. 2, 597–604 (2001).
28
P. J. Jorritsma, J. L. Brogdon, K. Bottomly, Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J. Immunol. 170, 2427–2434 (2003).
29
H. Yamane, J. Zhu, W. E. Paul, Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment. J. Exp. Med. 202, 793–804 (2005).
30
S. J. Van Dyken, J. C. Nussbaum, J. Lee, A. B. Molofsky, H. E. Liang, J. L. Pollack, R. E. Gate, G. E. Haliburton, C. J. Ye, A. Marson, D. J. Erle, R. M. Locksley, A tissue checkpoint regulates type 2 immunity. Nat. Immunol. 17, 1381–1387 (2016).
31
Y. Rochman, K. Dienger-Stambaugh, P. K. Richgels, I. P. Lewkowich, A. V. Kartashov, A. Barski, G. K. Khurana Hershey, W. J. Leonard, H. Singh, TSLP signaling in CD4+ T cells programs a pathogenic T helper 2 cell state. Sci. Signaling 11, eaam8858 (2018).
32
J. O. Ebinu et al., RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 280, 1082–1086 (1998).
33
R. P. Joshi, A. M. Schmidt, J. Das, D. Pytel, M. J. Riese, M. Lester, J. A. Diehl, E. M. Behrens, T. Kambayashi, G. A. Koretzky, The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Sci. Signal. 6, ra102 (2013).
34
X.-P. Zhong, E. A. Hainey, B. A. Olenchock, M. S. Jordan, J. S. Maltzman, K. E. Nichols, H. Shen, G. A. Koretzky, Enhanced T cell responses due to diacylglycerol kinase ζ deficiency. Nat. Immunol. 4, 882–890 (2003).
35
M. J. Riese, J. Grewal, J. Das, T. Zou, V. Patil, A. K. Chakraborty, G. A. Koretzky, Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses. J. Biol. Chem. 286, 5254–5265 (2011).
36
M. J. Riese, L.-C. S. Wang, E. K. Moon, R. P. Joshi, A. Ranganathan, C. H. June, G. A. Koretzky, S. M. Albelda, Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases. Cancer Res. 73, 3566–3577 (2013).
37
E. Yang, B. K. Singh, A. M. Paustian, T. Kambayashi, Diacylglycerol kinase ζ is a target to enhance NK cell function. J. Immunol. 197, 934–941 (2016).
38
B. A. Olenchock, R. Guo, M. A. Silverman, J. N. Wu, J. H. Carpenter, G. A. Koretzky, X.-P. Zhong, Impaired degranulation but enhanced cytokine production after Fc epsilonRI stimulation of diacylglycerol kinase ζ -deficient mast cells. J. Exp. Med. 203, 1471–1480 (2006).
39
B. K. Singh, T. Kambayashi, The immunomodulatory functions of diacylglycerol kinase ζ. Front. Cell Dev. Biol. 4, 96 (2016).
40
N. Noben-Trauth, J. Hu-Li, W. E. Paul, Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation. J. Immunol. 165, 3620–3625 (2000).
41
Z. Liu, Q. Liu, H. Hamed, R. M. Anthony, A. Foster, F. D. Finkelman, J. F. Urban Jr., W. C. Gause, IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites. J. Immunol. 174, 2242–2249 (2005).
42
M. Croft, S. L. Swain, Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 154, 4269–4282 (1995).
43
D. J. Erle, D. Sheppard, The cell biology of asthma. J. Cell Biol. 205, 621–631 (2014).
44
D. Tränkner, N. Hahne, K. Sugino, M. A. Hoon, C. Zuker, Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways. Proc. Natl. Acad. Sci. U.S.A. 111, 11515–11520 (2014).
45
A. Bergner, M. J. Sanderson, Acetylcholine-induced calcium signaling and contraction of airway smooth muscle cells in lung slices. J. Gen. Physiol. 119, 187–198 (2002).
46
L. Ding, T. M. McIntyre, G. A. Zimmerman, S. M. Prescott, The cloning and developmental regulation of murine diacylglycerol kinase ζ. FEBS Lett. 429, 109–114 (1998).
47
H. Sasaki, Y. Hozumi, H. Hasegawa, T. Ito, M. Takagi, T. Ogino, M. Watanabe, K. Goto, Gene expression and localization of diacylglycerol kinase isozymes in the rat spinal cord and dorsal root ganglia. Cell Tissue Res. 326, 35–42 (2006).
48
T. Nakano, Y. Hozumi, K. Goto, I. Wakabayashi, Localization of diacylglycerol kinase ε on stress fibers in vascular smooth muscle cells. Cell Tissue Res. 337, 167–175 (2009).
49
K. Nobe, M. Miyatake, H. Nobe, Y. Sakai, J. Takashima, K. Momose, Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions. Br. J. Pharmacol. 143, 166–178 (2004).
50
H. Choi, K. J. Allahdadi, R. C. A. Tostes, R. C. Webb, Diacylglycerol kinase inhibition and vascular function. Curr. Enzyme Inhib. 5, 148–152 (2009).
51
L. L. Sharp, D. A. Schwarz, C. M. Bott, C. J. Marshall, S. M. Hedrick, The influence of the MAPK pathway on T cell lineage commitment. Immunity 7, 609–618 (1997).
52
M. Sato, K. Liu, S. Sasaki, N. Kunii, H. Sakai, H. Mizuno, H. Saga, F. Sakane, Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method. Pharmacology 92, 99–107 (2013).
53
J. Arranz-Nicolás, J. Ogando, D. Soutar, R. Arcos-Pérez, D. Meraviglia-Crivelli, S. Mañes, I. Mérida, A. Ávila-Flores, Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals. Cancer Immunol. Immunother. 67, 965–980 (2018).
54
N. Goplen, Z. Karim, L. Guo, Y. Zhuang, H. Huang, M. M. Gorska, E. Gelfand, G. Pagés, J. Pouysségur, R. Alam, ERK1 is important for Th2 differentiation and development of experimental asthma. FASEB J. 26, 1934–1945 (2012).
55
C.-O. F. Chang, W. N. D’Souza, I. L. Ch’en, G. Pages, J. Pouyssegur, S. M. Hedrick, Polar opposites: Erk direction of CD4 T cell subsets. J. Immunol. 189, 721–731 (2012).
56
A. Agrawal, S. Dillon, T. L. Denning, B. Pulendran, ERK1−/− mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176, 5788–5796 (2006).
57
M. Yamashita, M. Kimura, M. Kubo, C. Shimizu, T. Tada, R. M. Perlmutter, T. Nakayama, T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 96, 1024–1029 (1999).
58
Y. Shibata, T. Kamata, M. Kimura, M. Yamashita, C.-R. Wang, K. Murata, M. Miyazaki, M. Taniguchi, N. Watanabe, T. Nakayama, Ras activation in T cells determines the development of antigen-induced airway hyperresponsiveness and eosinophilic inflammation. J. Immunol. 169, 2134–2140 (2002).
59
A. M. Schmidt, T. Zou, R. P. Joshi, T. M. Leichner, M. A. Pimentel, C. L. Sommers, T. Kambayashi, Diacylglycerol kinase ζ limits the generation of natural regulatory T cells. Sci. Signal. 6, ra101 (2013).
60
J. Das, C. H. Chen, L. Yang, L. Cohn, P. Ray, A. Ray, A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2, 45–50 (2001).
61
M. P. Caulfield, Muscarinic receptors—Characterization, coupling and function. Pharmacol. Ther. 58, 319–379 (1993).
62
H. R. Kim, M. Hoque, C.-M. Hai, Cholinergic receptor-mediated differential cytoskeletal recruitment of actin- and integrin-binding proteins in intact airway smooth muscle. Am. J. Physiol. Cell Physiol. 287, C1375–C1383 (2004).
63
C. Dessy, I. Kim, C. L. Sougnez, R. Laporte, K. G. Morgan, A role for MAP kinase in differentiated smooth muscle contraction evoked by α-adrenoceptor stimulation. Am. J. Physiol. 275, C1081–C1086 (1998).
64
E. Ihara, Q. Yu, M. Chappellaz, J. A. MacDonald, ERK and p38MAPK pathways regulate myosin light chain phosphatase and contribute to Ca2+ sensitization of intestinal smooth muscle contraction. Neurogastroenterol. Motil. 27, 135–146 (2015).
65
D. A. Taylor, J. T. Stull, Calcium dependence of myosin light chain phosphorylation in smooth muscle cells. J. Biol. Chem. 263, 14456–14462 (1988).
66
A. P. Somlyo, A. V. Somlyo, Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83, 1325–1358 (2003).
67
T. Kitazawa, M. Eto, T. P. Woodsome, M. Khalequzzaman, Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. J. Physiol. 546, 879–889 (2003).
68
S. H. Ryu, U.-H. Kim, M. I. Wahl, A. B. Brown, G. Carpentern, K.-P. Huang, S. G. Rhee, Feedback regulation of phospholipase C-β by protein kinase C. J. Biol. Chem. 265, 17941–17945 (1990).
69
K. Ozawa, K. Yamada, M. G. Kazanietz, P. M. Blumberg, M. A. Beaven, Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells. J. Biol. Chem. 268, 2280–2283 (1993).
70
M. Noonan, P. Korenblat, S. Mosesova, H. Scheerens, J. R. Arron, Y. Zheng, W. S. Putnam, M. V. Parsey, S. P. Bohen, J. G. Matthews, Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. J. Allergy Clin. Immunol. 132, 567–574.e512 (2013).
71
Y. Liu, S. Zhang, D. W. Li, S. J. Jiang, Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: A meta-analysis of randomized placebo-controlled trials. PLOS ONE 8, e59872 (2013).
72
C.-H. Liu, F. S. Machado, R. Guo, K. E. Nichols, A. W. Burks, J. C. Aliberti, X.-P. Zhong, Diacylglycerol kinase ζ regulates microbial recognition and host resistance to Toxoplasma gondii. J. Exp. Med. 204, 781–792 (2007).
73
M. Anderson, Q. Zheng, X. Dong, Investigation of pain mechanisms by calcium imaging approaches. Neurosci. Bull. 34, 194–199 (2018).
74
Q. Yang, M. Q. Ge, B. Kokalari, I. G. Redai, X. Wang, D. M. Kemeny, A. Bhandoola, A. F. Haczku, Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 137, 571–578 (2016).
75
S. K. Sharma, F. A. Almeida, S. Kierstein, L. Hortobagyi, T. Lin, A. Larkin, J. Peterson, H. Yagita, J. G. Zangrilli, A. Haczku, Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma. Allergy 67, 328–335 (2012).
76
S. Kierstein, K. Krytska, S. Sharma, Y. Amrani, M. Salmon, R. A. Panettieri, J. Zangrilli, A. Haczku, Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy 63, 438–446 (2008).
77
S. Kierstein, F. R. Poulain, Y. Cao, M. Grous, R. Mathias, G. Kierstein, M. F. Beers, M. Salmon, R. A. Panettieri, A. Haczku, Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respir. Res. 7, 85 (2006).
78
A. Haczku, E. N. Atochina, Y. Tomer, Y. Cao, C. Campbell, S. T. Scanlon, S. J. Russo, G. Enhorning, M. F. Beers, The late asthmatic response is linked with increased surface tension and reduced surfactant protein B in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L755–L765 (2002).
79
Z. Jiang, M. L. Fehrenbach, G. Ravaioli, B. Kokalari, I. G. Redai, S. A. Sheardown, S. Wilson, C. Macphee, A. Haczku, The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. Respir. Res. 13, 100 (2012).
80
D. A. Deshpande, B. S. Theriot, R. B. Penn, J. K. Walker, β-Arrestins specifically constrain β2-adrenergic receptor signaling and function in airway smooth muscle. FASEB J. 22, 2134–2141 (2008).
81
P. R. Cooper, R. A. Panettieri, Steroids completely reverse albuterol-induced β2-adrenergic receptor tolerance in human small airways. J. Allergy Clin. Immunol. 122, 734–740 (2008).
82
R. A. Panettieri, R. K. Murray, L. R. DePalo, P. A. Yadvish, M. I. Kotlikoff, A human airway smooth muscle cell line that retains physiological responsiveness. Am. J. Physiol. 256, C329–C335 (1989).

Information & Authors

Information

Published In

Science Signaling
Volume 12 | Issue 597
September 2019

Submission history

Received: 14 March 2019
Accepted: 9 August 2019

Permissions

Request permissions for this article.

Acknowledgments

We thank all members of the Kambayashi, Behrens, Koretzky, Su, Oliver, Silverman, Jordan, and Bassiri laboratories for the advice. We thank L. Samuelson (National Institutes of Health) and C. Sommers (National Institutes of Health) for providing us with the sevenmaker mice. We thank M. Li for carefully reviewing the statistical analyses performed in our studies. Funding: This work was supported by grants from the American Asthma Foundation (to T.K.), Tobacco-Related Disease Research Program (to A.H.), and the National Institutes of Health (F31-HL134325 to B.K.S.; T32HL007013 and T32ES007059 to C.H.F.; R21AI116121 and R01AI072197 to A.H.; and R01HL107589, R01HL111501, R01AI121250, and R01HL146645 to T.K.) Author contributions: B.K.S., W.L., A.M.S.P., A.H., R.A.P., D.A.D., and T.K. designed the experiments. B.K.S., W.L., A.M.S.P., M.Q.G., N.W., C.J.K.-W., and T.K. performed the experiments. C.H.F. and S.S.K. scored the histopathological specimens. M.J.R. and X.D. provided valuable reagents. T.K. conceived and supervised the project. The manuscript was written by B.K.S. and T.K. and edited by all authors. Competing interests: The authors declare that they have no competing financial interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials.

Authors

Affiliations

Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Wen Lu*
Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Amanda M. Schmidt Paustian https://orcid.org/0000-0001-9031-0595
Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Moyar Q. Ge
Pulmonary, Critical Care and Sleep Division, University of California, Davis, Davis, CA 95616, USA.
Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ 08901, USA.
Pulmonary, Critical Care and Sleep Division, University of California, Davis, Davis, CA 95616, USA.
Sara S. Killingbeck
Pulmonary, Critical Care and Sleep Division, University of California, Davis, Davis, CA 95616, USA.
Nadan Wang
Department of Medicine, Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Xinzhong Dong
The Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
Matthew J. Riese
Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53226, USA.
Deepak A. Deshpande
Department of Medicine, Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Reynold A. Panettieri Jr.
Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ 08901, USA.
Pulmonary, Critical Care and Sleep Division, University of California, Davis, Davis, CA 95616, USA.
Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.

Funding Information

National Institutes of Health: R21AI116121, R01AI072197
National Institutes of Health: R01HL107589, R01HL111501, R01AI121250, R01HL146645

Notes

*
These authors contributed equally to this work.
†Corresponding author. Email: [email protected]

Metrics & Citations

Metrics

Article Usage
Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. Autocrine regulation of airway smooth muscle contraction by diacylglycerol kinase, Journal of Cellular Physiology, (2021).https://doi.org/10.1002/jcp.30528
    Crossref
  2. Potential role of diacylglycerol kinases in immune-mediated diseases, Clinical Science, 134, 13, (1637-1658), (2020).https://doi.org/10.1042/CS20200389
    Crossref
  3. Editorial overview: Pulmonary 2020 – advances in the pharmacology of obstructive lung diseases, Current Opinion in Pharmacology, 51, (iii-vii), (2020).https://doi.org/10.1016/j.coph.2020.08.016
    Crossref
  4. The role of diacylglycerol kinases in allergic airway disease, Current Opinion in Pharmacology, 51, (50-58), (2020).https://doi.org/10.1016/j.coph.2020.07.008
    Crossref
  5. Beyond Lipid Signaling: Pleiotropic Effects of Diacylglycerol Kinases in Cellular Signaling, International Journal of Molecular Sciences, 21, 18, (6861), (2020).https://doi.org/10.3390/ijms21186861
    Crossref
  6. DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases, International Journal of Molecular Sciences, 20, 22, (5673), (2019).https://doi.org/10.3390/ijms20225673
    Crossref
Loading...

View Options

Get Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media